Navigating the Evolving Life Sciences Landscape: Strengthening IP Strategy for Long-Term Value Creation
In recent years, rapid advances in innovation, digitalisation and globalisation have transformed the life sciences IP landscape, while increasing pressure to minimise costs and maximise resources has reshaped strategic priorities. Coupled with evolving regulatory frameworks and increasing cross-border challenges, these changes present significant challenges for IP leaders seeking to protect innovation, manage risk, and maximise portfolio value.
On 25th November 2026, join 60+ senior IP leaders from across the pharma and biotech industries in Europe to discuss how to ensure an adaptable and future-proof IP strategy.
Session Leaders Include:
What to expect:
“My key takeaway is that the format worked very well - this is easily the conference that I have gotten the most out of in years (also counting countless "in-person" meetings). The roundtable discussions worked extremely well and the topics were very relevant to me and I got a lot of inspiration for my work.” - Vice President, Corporate Patents, Pharmaceutical Company
“Very informative. A professionally run forum with open and engaging panellists. Good selection of participants with range of different experiences and perspectives.” - VP Intellectual Property Strategy & Litigation, Biotech
“I really enjoyed the format as it brought together small teams of practitioners from diverse backgrounds to allow a meaningful discussion.” - Head of Patents, Pharma and Consumer Health, Pharmaceutical Company